Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Fukutake

Showing results (51-60 of 155) with videos related to

Pageof 16
Sort By:
International Journal of Hematology|August 24, 2006
Clinical evaluation of recombinant factor VIII preparation (Kogenate) in previously treated patients with hemophilia A: descriptive meta-analysis of post-marketing study dataA Yoshioka, K Fukutake, J Takamatsu, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 1, 1976
[Determination of factors V,VII and X]K Fukutake, Y Matsubara, H Tamura, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|December 1, 1973
[Investigation and treatment of hemophilia A with inhibitor of factor VIII (author's transl)]K Fukutake, M Fujimari, M Ukita, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology|February 1, 1986
[Evaluation of the assay for fibrin derivatives using monoclonal antibodies to D-dimer]M Arai, K Kuroso, S Ikematsu, et al.
International Journal of Hematology|September 9, 2000
Pharmacokinetics, prophylactic effects, and safety of a new recombinant FVIII formulated with sucrose (BAY 14-2222) in Japanese patients with hemophilia AA Shirahata, K Fukutake, J Takamatsu, et al.
Life Sciences|January 1, 1992
A cAMP-dependent protein kinase inhibitor modulates the blocking action of ATP and 5-hydroxydecanoate on the ATP-sensitive K+ channelT Notsu, I Tanaka, M Mizota, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology|November 1, 1981
[Determination of serum triglyceride using 4-amino-3-hydrazino-5-mercapto-1,2,4-triazole (II)]M Fujiwara, S Tomita, K Tago, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology|December 1, 1992
[Evaluation of novel assays for the detection of crosslinked fibrin degradation products in whole blood by the agglutination of the red blood cells]K Kuroso, N Isogai, K Koike, et al.
Shika Gakuho. Dental Science Reports|February 1, 1980
[Immediate reconstruction for enlarged cancer of gingiva in the middle mandible (author's transl)]K Fukutake, S Nakajima, H Sugaya, et al.
Thrombosis Research|January 1, 1982
Possible cross-linking of factor VIII related antigen to fibrin by factor XIII in delayed coagulation processM Hada, M Kato, S Ikematsu, et al.
Pageof 16

Showing results (51-60 of 155) with videos related to

Sort By:
Pageof 16
International Journal of Hematology|August 24, 2006
Clinical evaluation of recombinant factor VIII preparation (Kogenate) in previously treated patients with hemophilia A: descriptive meta-analysis of post-marketing study dataA Yoshioka, K Fukutake, J Takamatsu, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 1, 1976
[Determination of factors V,VII and X]K Fukutake, Y Matsubara, H Tamura, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|December 1, 1973
[Investigation and treatment of hemophilia A with inhibitor of factor VIII (author's transl)]K Fukutake, M Fujimari, M Ukita, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology|February 1, 1986
[Evaluation of the assay for fibrin derivatives using monoclonal antibodies to D-dimer]M Arai, K Kuroso, S Ikematsu, et al.
International Journal of Hematology|September 9, 2000
Pharmacokinetics, prophylactic effects, and safety of a new recombinant FVIII formulated with sucrose (BAY 14-2222) in Japanese patients with hemophilia AA Shirahata, K Fukutake, J Takamatsu, et al.
Life Sciences|January 1, 1992
A cAMP-dependent protein kinase inhibitor modulates the blocking action of ATP and 5-hydroxydecanoate on the ATP-sensitive K+ channelT Notsu, I Tanaka, M Mizota, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology|November 1, 1981
[Determination of serum triglyceride using 4-amino-3-hydrazino-5-mercapto-1,2,4-triazole (II)]M Fujiwara, S Tomita, K Tago, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology|December 1, 1992
[Evaluation of novel assays for the detection of crosslinked fibrin degradation products in whole blood by the agglutination of the red blood cells]K Kuroso, N Isogai, K Koike, et al.
Shika Gakuho. Dental Science Reports|February 1, 1980
[Immediate reconstruction for enlarged cancer of gingiva in the middle mandible (author's transl)]K Fukutake, S Nakajima, H Sugaya, et al.
Thrombosis Research|January 1, 1982
Possible cross-linking of factor VIII related antigen to fibrin by factor XIII in delayed coagulation processM Hada, M Kato, S Ikematsu, et al.
Pageof 16